Thieltges, Katherine M.
Avramovic, Dragana
Piscitelli, Chayne L.
Markovic-Mueller, Sandra
Binz, Hans Kaspar
Ballmer-Hofer, Kurt http://orcid.org/0000-0002-3800-9129
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_152908)
Oncosuisse (KLS-3569-02-2015)
Article History
Received: 18 December 2017
Accepted: 17 February 2018
First Online: 3 March 2018
Compliance with ethical standards
:
: HKB is shareholder of Molecular Partners AG commercializing the DARPinSuperscript removedTechnology. The other authors do not declare competing financial interests.